Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-06-19
1992-09-15
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514220, A01N 4362, A61K 3155
Patent
active
051478722
ABSTRACT:
Methods and means for treating psoriasis, as well as Crohn's disease and other HLA-related disorders, to abate their symptoms, with a pharmaceutical diazepine having a component triazolo ring. HLA-related disorders amenable to such treatment include (i) persistent eruptive, granular, or ulcerative conditions of the skin, mouth, or gastrointestinal tract; and (ii) dibilitating inflammatory conditions of the circulatory, muscular, and nervous systems. This treatment alleviates abnormality or unbalance of patients' immune systems, such as an overabundance of natural killer cells and/or an abnormality of helper T-cell/suppressor T-cell ratio, and alleviates the self-cannibilism of the Koebner phenomenon, when present. Triazolobenzodiazepines, such as alprazolam or triazolam, and triazolothienodiazepines, such as etizolam, are examples of preferred treating compositions.
McClure Charles A.
Nutter Nathan M.
LandOfFree
Treatment of immunologically based disorders, specifically psori does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of immunologically based disorders, specifically psori, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of immunologically based disorders, specifically psori will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-736891